Karl A Nath1, Raman Deep Singh1, Joseph P Grande2, Vesna D Garovic1, Anthony J Croatt1, Allan W Ackerman1, Michael A Barry3, Anupam Agarwal4. 1. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota. 2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. 3. Division of Infectious Diseases, Mayo Clinic Rochester, Minnesota. 4. Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
Background: The actions of angiotensin-converting enzyme 2 (ACE2) oppose those of the renin-angiotensin-aldosterone system. ACE2 may be a cytoprotectant in some tissues. This study examined ACE2 expression in models of AKI. Methods: ACE2 mRNA and protein expression and ACE2 activity were assessed in murine ischemic AKI. Renal ACE2 mRNA expression was evaluated in LPS-induced AKI in wild-type (C57BL/6J) mice, in heme oxygenase-1+/+ and heme oxygenase-1-/- mice, and after unilateral ureteral obstruction (UUO) in wild-type mice. The effect of sex and age on renal ACE2 protein expression was also assessed. Results: In ischemic AKI, ACE2 mRNA and protein expression and ACE2 activity were reduced as compared with such indices in the intact kidney. In ischemic AKI, ACE2, which, in health, is prominently expressed in the tubular epithelium, especially proximal tubules, is decreased in expression in these segments. Decreased ACE2 expression in AKI did not reflect reduced GFR, because ACE2 mRNA expression was unaltered after UUO. LPS induced renal ACE2 mRNA expression in wild-type mice, but this effect did not occur in heme oxygenase-1-deficient mice. In ischemic and LPS-induced AKI, renal expression of the Mas receptor was increased. In the intact kidney, renal ACE2 protein expression decreased in female mice as compared with male mice, but was unaltered with age. Conclusion: We conclude that renal ACE2 expression is decreased in ischemic AKI, characterized by decreased GFR and abundant cell death, but is upregulated in LPS-induced AKI, an effect requiring heme oxygenase-1. Determining the significance of ACE2 expression in experimental AKI merits further study. We suggest that understanding the mechanism underlying ACE2 downregulation in AKI may offer insights relevant to COVID-19: ACE2 expression is downregulated after ACE2 mediates SARS-CoV-2 cellular entry; such downregulation is proinflammatory; and AKI commonly occurs and determines outcomes in COVID-19.
Background: The actions of angiotensin-converting enzyme 2 (ACE2) oppose those of the renin-angiotensin-aldosterone system. ACE2 may be a cytoprotectant in some tissues. This study examined ACE2 expression in models of AKI. Methods: ACE2 mRNA and protein expression and ACE2 activity were assessed in murine ischemic AKI. Renal ACE2 mRNA expression was evaluated in LPS-induced AKI in wild-type (C57BL/6J) mice, in heme oxygenase-1+/+ and heme oxygenase-1-/- mice, and after unilateral ureteral obstruction (UUO) in wild-type mice. The effect of sex and age on renal ACE2 protein expression was also assessed. Results: In ischemic AKI, ACE2 mRNA and protein expression and ACE2 activity were reduced as compared with such indices in the intact kidney. In ischemic AKI, ACE2, which, in health, is prominently expressed in the tubular epithelium, especially proximal tubules, is decreased in expression in these segments. Decreased ACE2 expression in AKI did not reflect reduced GFR, because ACE2 mRNA expression was unaltered after UUO. LPS induced renal ACE2 mRNA expression in wild-type mice, but this effect did not occur in heme oxygenase-1-deficient mice. In ischemic and LPS-induced AKI, renal expression of the Mas receptor was increased. In the intact kidney, renal ACE2 protein expression decreased in female mice as compared with male mice, but was unaltered with age. Conclusion: We conclude that renal ACE2 expression is decreased in ischemic AKI, characterized by decreased GFR and abundant cell death, but is upregulated in LPS-induced AKI, an effect requiring heme oxygenase-1. Determining the significance of ACE2 expression in experimental AKI merits further study. We suggest that understanding the mechanism underlying ACE2 downregulation in AKI may offer insights relevant to COVID-19: ACE2 expression is downregulated after ACE2 mediates SARS-CoV-2 cellular entry; such downregulation is proinflammatory; and AKI commonly occurs and determines outcomes in COVID-19.
Authors: Kátia D da Silveira; Kênia S Pompermayer Bosco; Lúcio R L Diniz; Adriana K Carmona; Giovanni D Cassali; Oscar Bruna-Romero; Lirlândia P de Sousa; Mauro M Teixeira; Robson A S Santos; Ana C Simões e Silva; Maria A Ribeiro Vieira Journal: Clin Sci (Lond) Date: 2010-07-23 Impact factor: 6.124
Authors: Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic Journal: Am J Pathol Date: 2005-04 Impact factor: 4.307
Authors: Hong Ji; Aline M A de Souza; Bilkish Bajaj; Wei Zheng; Xie Wu; Robert C Speth; Kathryn Sandberg Journal: Hypertension Date: 2020-06-22 Impact factor: 10.190
Authors: Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic Journal: Hypertension Date: 2020-09-28 Impact factor: 10.190
Authors: M J Tracz; J P Juncos; A J Croatt; A W Ackerman; J P Grande; K L Knutson; G C Kane; A Terzic; M D Griffin; K A Nath Journal: Kidney Int Date: 2007-08-29 Impact factor: 10.612
Authors: Karl A Nath; Raman Deep Singh; Anthony J Croatt; Allan W Ackerman; Joseph P Grande; Khasayarsha Khazaie; Y Eugene Chen; Jifeng Zhang Journal: Kidney360 Date: 2022-05-06